Galecto, Inc. financial data

Symbol
GLTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
75 State Street, Suite 100, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 697 % +64.2%
Debt-to-equity 15.6 % -43.7%
Return On Equity -80.7 % +15.2%
Return On Assets -69.8 % +6.35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.32M shares -95.1%
Common Stock, Shares, Outstanding 1.25M shares -95.4%
Weighted Average Number of Shares Outstanding, Basic 1.14M shares +5.61%
Weighted Average Number of Shares Outstanding, Diluted 1.14M shares +5.61%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.16M USD -74.3%
General and Administrative Expense 12M USD -2.25%
Operating Income (Loss) -21.8M USD +53.3%
Nonoperating Income (Expense) 705K USD -13.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.88M USD +52.4%
Income Tax Expense (Benefit) 7K USD
Net Income (Loss) Attributable to Parent -21.2M USD +53.9%
Earnings Per Share, Basic -31.5 USD/shares -251%
Earnings Per Share, Diluted -31.5 USD/shares -251%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.7M USD -14.7%
Assets, Current 21.2M USD -55%
Property, Plant and Equipment, Net 62K USD -50.4%
Operating Lease, Right-of-Use Asset 32K USD -92.9%
Other Assets, Noncurrent 2.1M USD -13%
Assets 23.4M USD -53.3%
Accounts Payable, Current 503K USD -88.8%
Employee-related Liabilities, Current 809K USD -80%
Accrued Liabilities, Current 1.94M USD -76%
Liabilities, Current 2.44M USD -80.6%
Liabilities 2.44M USD -80.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 665K USD +1346%
Retained Earnings (Accumulated Deficit) -271M USD -8.48%
Stockholders' Equity Attributable to Parent 20.9M USD -44%
Liabilities and Equity 23.4M USD -53.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 1.25M shares -95.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.7M USD -14.7%
Operating Lease, Liability 32K USD -93.1%
Depreciation 39K USD -85.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.6M USD +53.3%
Lessee, Operating Lease, Liability, to be Paid 33K USD -93.3%
Property, Plant and Equipment, Gross 107K USD -75.1%
Operating Lease, Liability, Current 32K USD -90.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 361K USD -34.2%
Additional Paid in Capital 291M USD +1.43%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.02M USD -29.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%